Pub Date : 2024-04-01DOI: 10.1016/j.jviscsurg.2023.06.004
Gerd Jomrich , Maximilian Gruber , Elisabeth S. Gruber , Jakob Mühlbacher , Sanja Radosavljevic , Lavinia Wilfing , Daniel Winkler , Gerald Prager , Christian Reiterer , Barbara Kabon , Helmuth Haslacher , Klaus Sahora , Martin Schindl
Aim of the study
Mean corpuscular volume (MCV) has shown mounting evidence as a prognostic indicator in a number of malignancies. The aim of this study was to examine the prognostic potential of pretherapeutic MCV among patients with pancreatic ductal adenocarcinoma (PDAC) who underwent upfront resection or resection after neoadjuvant treatment (NT).
Patients and methods
Consecutive patients with PDAC who underwent pancreatic resection between 1997 and 2019 were included in this study. Neoadjuvantly treated patients’ serum MCV was measured before NT and before surgery. In patients undergoing upfront resection serum MCV was measured before surgery. Median MCV values were used as cut-off to distinguish high from low MCV values.
Results
Five hundred and forty-nine (438 upfront resected and 111 neoadjuvantly treated) patients were included in this study. Multivariate analysis revealed, that high MCV before and after NT, were independent negative prognostic factors for overall survival (P < 0.01, respectively). Furthermore, the median MCV value from before to after NT increased significantly (P < 0.001, Wilcoxon signed-rank test) and was (P = 0.03, Wilcoxon rank sum test) associated with tumor response to NT.
Conclusion
High MCV is an independent adverse prognostic factor in patients with resectable neoadjuvantly treated PDAC and may qualify as useful indicator to help physicians to provide personalized prognostication.
{"title":"Prognostic significance of mean corpuscular volume in patients with pancreatic ductal adenocarcinoma and multimodal treatment","authors":"Gerd Jomrich , Maximilian Gruber , Elisabeth S. Gruber , Jakob Mühlbacher , Sanja Radosavljevic , Lavinia Wilfing , Daniel Winkler , Gerald Prager , Christian Reiterer , Barbara Kabon , Helmuth Haslacher , Klaus Sahora , Martin Schindl","doi":"10.1016/j.jviscsurg.2023.06.004","DOIUrl":"10.1016/j.jviscsurg.2023.06.004","url":null,"abstract":"<div><h3>Aim of the study</h3><p>Mean corpuscular volume (MCV) has shown mounting evidence as a prognostic indicator in a number of malignancies. The aim of this study was to examine the prognostic potential of pretherapeutic MCV among patients with pancreatic ductal adenocarcinoma (PDAC) who underwent upfront resection or resection after neoadjuvant treatment (NT).</p></div><div><h3>Patients and methods</h3><p>Consecutive patients with PDAC who underwent pancreatic resection between 1997 and 2019 were included in this study. Neoadjuvantly treated patients’ serum MCV was measured before NT and before surgery. In patients undergoing upfront resection serum MCV was measured before surgery. Median MCV values were used as cut-off to distinguish high from low MCV values.</p></div><div><h3>Results</h3><p>Five hundred and forty-nine (438 upfront resected and 111 neoadjuvantly treated) patients were included in this study. Multivariate analysis revealed, that high MCV before and after NT, were independent negative prognostic factors for overall survival (<em>P</em> <!--><<!--> <!-->0.01, respectively). Furthermore, the median MCV value from before to after NT increased significantly (<em>P</em> <!--><<!--> <!-->0.001, Wilcoxon signed-rank test) and was (<em>P</em> <!-->=<!--> <!-->0.03, Wilcoxon rank sum test) associated with tumor response to NT.</p></div><div><h3>Conclusion</h3><p>High MCV is an independent adverse prognostic factor in patients with resectable neoadjuvantly treated PDAC and may qualify as useful indicator to help physicians to provide personalized prognostication.</p></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"161 2","pages":"Pages 99-105"},"PeriodicalIF":2.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1878788623001157/pdfft?md5=136b81cbab7dea632490fb3df598e3a2&pid=1-s2.0-S1878788623001157-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9718667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Environmental factors contribute to more than 25% of all global disease but as medical student, we consider that environmental health is insufficiently taught. We are not armed for facing patient's questions, prevent diseases linked to environmental exposure and adapt care in susceptible population.
Material and methods
We conducted a national French survey, using a web-based questionnaire from October to November 2021. All medical students were interrogated to assess their knowledge on environmental health and their desire to obtain a specific curriculum on this topic.
Results
Two hundred and thirty-two students responded to the survey and most (62.7%) had never had any teaching on environmental health during their medical studies. The majority claimed to have no knowledge on environmental health (63.6%), and most had never been read or seen media content about it (59.2%). Those who had knowledge on environmental health, had been informed through social media, questioning the reliability of this content. Most (87.3%) were ready to take a specific course on environmental health issues during their medical studies in order to better inform their patients with evidence-based medicine and identify at risk population.
Conclusion
Through a survey, we identified the need and the emergency of implanting a curriculum on environmental medicine in our medical education.
{"title":"Environmental health in medical schools in France: A call from medical students","authors":"Anouk Grobon , Florence Huang , Glenn Simon-Rivé , Louise Benoit , Meriem Koual","doi":"10.1016/j.jviscsurg.2023.10.004","DOIUrl":"10.1016/j.jviscsurg.2023.10.004","url":null,"abstract":"<div><h3>Objective</h3><p><span>Environmental factors<span> contribute to more than 25% of all global disease but as medical student, we consider that environmental health is insufficiently taught. We are not armed for facing patient's questions, prevent diseases linked to environmental exposure and adapt care in </span></span>susceptible population.</p></div><div><h3>Material and methods</h3><p>We conducted a national French survey, using a web-based questionnaire from October to November 2021. All medical students were interrogated to assess their knowledge on environmental health and their desire to obtain a specific curriculum on this topic.</p></div><div><h3>Results</h3><p>Two hundred and thirty-two students responded to the survey and most (62.7%) had never had any teaching on environmental health during their medical studies. The majority claimed to have no knowledge on environmental health (63.6%), and most had never been read or seen media content about it (59.2%). Those who had knowledge on environmental health, had been informed through social media, questioning the reliability of this content. Most (87.3%) were ready to take a specific course on environmental health issues during their medical studies in order to better inform their patients with evidence-based medicine and identify at risk population.</p></div><div><h3>Conclusion</h3><p>Through a survey, we identified the need and the emergency of implanting a curriculum on environmental medicine in our medical education.</p></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"161 2","pages":"Pages 21-24"},"PeriodicalIF":2.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The objective of this systematic review of the literature is to compare a selection of currently utilized disposable and reusable laparoscopic medical devices in terms of safety (1st criteria), cost and carbon footprint.
Material and methods
A search was carried out on electronic databases for articles published up until 6 May 2022. The eligible works were prospective (randomized or not) or retrospective clinical or medical-economic comparative studies having compared disposable scissors, trocars, and mechanical endoscopic staplers to the same instruments in reusable. Two different independent examiners extracted the relevant data.
Results
Among the 2882 articles found, 156 abstracts were retained for examination. After comprehensive analysis concerning the safety and effectiveness of the instruments, we included four articles. A study on trocars highlighted increased vascular complications with disposable instruments, and another study found more perioperative incidents with a hybrid stapler as opposed to a disposable stapler. As regards cost analysis, we included 11 studies, all of which showed significantly higher costs with disposable instruments.
The results of the one study on carbon footprints showed that hybrid instruments leave four times less of a carbon footprint than disposable instruments.
Conclusion
The literature on the theme remains extremely limited. Our review demonstrated that from a medical and economic standpoint, reusable medical instruments, particularly trocars, presented appreciable advantages. While there exist few data on the ecological impact, those that do exist are unmistakably favorable to reusable instruments.
{"title":"A systematic review comparing the safety, cost and carbon footprint of disposable and reusable laparoscopic devices","authors":"Pauline Chauvet , Audrey Enguix , Valérie Sautou , Karem Slim","doi":"10.1016/j.jviscsurg.2023.10.006","DOIUrl":"10.1016/j.jviscsurg.2023.10.006","url":null,"abstract":"<div><h3>Introduction</h3><p>The objective of this systematic review<span> of the literature is to compare a selection of currently utilized disposable and reusable laparoscopic medical devices in terms of safety (1st criteria), cost and carbon footprint.</span></p></div><div><h3>Material and methods</h3><p>A search was carried out on electronic databases for articles published up until 6 May 2022. The eligible works were prospective (randomized or not) or retrospective clinical or medical-economic comparative studies having compared disposable scissors, trocars, and mechanical endoscopic staplers to the same instruments in reusable. Two different independent examiners extracted the relevant data.</p></div><div><h3>Results</h3><p>Among the 2882 articles found, 156 abstracts were retained for examination. After comprehensive analysis concerning the safety and effectiveness of the instruments, we included four articles. A study on trocars highlighted increased vascular complications with disposable instruments, and another study found more perioperative incidents with a hybrid stapler as opposed to a disposable stapler. As regards cost analysis, we included 11 studies, all of which showed significantly higher costs with disposable instruments.</p><p>The results of the one study on carbon footprints showed that hybrid instruments leave four times less of a carbon footprint than disposable instruments.</p></div><div><h3>Conclusion</h3><p>The literature on the theme remains extremely limited. Our review demonstrated that from a medical and economic standpoint, reusable medical instruments, particularly trocars, presented appreciable advantages. While there exist few data on the ecological impact, those that do exist are unmistakably favorable to reusable instruments.</p></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"161 2","pages":"Pages 25-31"},"PeriodicalIF":2.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139555464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.1016/j.jviscsurg.2024.01.004
Karem Slim , Gilles Tilmans , Bob Valéry Occéan , Chadly Dziri , Bruno Pereira , Michel Canis
Introduction
Robotic surgery (RS) is experiencing major development, particularly in the context of rectal cancer. The aim of this meta-analysis was to summarize data from the literature, focusing specifically on the safety and effectiveness of robotic surgery in mid-low rectal cancers, based on the hypothesis that that robotic surgery can find its most rational indication in this anatomical location.
Method
The meta-analysis was conducted according to the PRISMA 2000 recommendations, including all randomized trials that compared robotic surgery versus laparoscopic surgery (LS) that were found in the Medline-PICO, Cochrane Database, Scopus and Google databases. Data were extracted independently by two reviewers. The risk of bias was analyzed according to the Cochrane Handbook method and the certainty of the evidence according to the GRADE method. The analysis was carried out with R software Version 4.2-3 using the Package for Meta-Analysis “meta” version 6.5-0.
Results
Eight randomized trials were included (with a total of 2342 patients), including four that focused specifically on mid-low rectal cancer (n = 1,734 patients). No statistically significant difference was found for overall morbidity, intra-operative morbidity, anastomotic leakage, post-operative mortality, quality of mesorectal specimen, and resection margins. The main differences identified were a lower conversion rate for RS (RR = 0.48 [0.24–0.95], p = 0.04, I2 = 0%), and a longer operative time for RS (mean difference = 39.11 min [9.39–68.83], p < 0.01, I2 = 96%). The other differences had no real clinical relevance, i.e., resumption of flatus passage (5 hours earlier after RS), and lymph node dissection (one more lymph node for LS).
Conclusion
This meta-analysis does not confirm the initial hypothesis and does not show a statistically significant or clinically relevant benefit of RS compared to LS for mid-low rectal cancer.
简介:机器人手术(RS)正在经历重大发展,尤其是在直肠癌方面:机器人手术(RS)正在经历重大发展,尤其是在直肠癌方面。本荟萃分析旨在总结文献数据,特别关注机器人手术在中低位直肠癌中的安全性和有效性,其假设是机器人手术能在这一解剖位置找到最合理的适应症:荟萃分析根据 PRISMA 2000 建议进行,包括在 Medline-PICO、Cochrane 数据库、Scopus 和 Google 数据库中找到的所有比较机器人手术与腹腔镜手术(LS)的随机试验。数据由两名审稿人独立提取。根据《Cochrane手册》方法分析偏倚风险,根据GRADE方法分析证据的确定性。分析采用 R 软件 4.2-3 版,使用 Meta 分析软件包 "meta "6.5-0 版:共纳入 8 项随机试验(共 2342 名患者),其中 4 项试验专门针对中低位直肠癌(n=1734 名患者)。在总发病率、术中发病率、吻合口漏、术后死亡率、直肠间质标本质量和切除边缘方面,均未发现有统计学意义的差异。发现的主要差异是 RS 的转换率较低(RR=0.48 [0.24-0.95],P=0.04,I2=0%),RS 的手术时间较长(平均差异=39.11 分钟 [9.39-68.83],P2=96%)。其他差异与临床无关,即恢复排便(RS术后提前5小时)和淋巴结清扫(LS术后多一个淋巴结):这项荟萃分析没有证实最初的假设,也没有显示 RS 与 LS 相比对中低位直肠癌有统计学意义或临床相关的益处。
{"title":"Meta-analysis of randomized clinical trials comparing robotic versus laparoscopic surgery for mid-low rectal cancers","authors":"Karem Slim , Gilles Tilmans , Bob Valéry Occéan , Chadly Dziri , Bruno Pereira , Michel Canis","doi":"10.1016/j.jviscsurg.2024.01.004","DOIUrl":"10.1016/j.jviscsurg.2024.01.004","url":null,"abstract":"<div><h3>Introduction</h3><p>Robotic surgery (RS) is experiencing major development, particularly in the context of rectal cancer. The aim of this meta-analysis was to summarize data from the literature, focusing specifically on the safety and effectiveness of robotic surgery in mid-low rectal cancers, based on the hypothesis that that robotic surgery can find its most rational indication in this anatomical location.</p></div><div><h3>Method</h3><p>The meta-analysis was conducted according to the PRISMA 2000 recommendations, including all randomized trials that compared robotic surgery <em>versus</em> laparoscopic surgery (LS) that were found in the Medline-PICO, Cochrane Database, Scopus and Google databases. Data were extracted independently by two reviewers. The risk of bias was analyzed according to the Cochrane Handbook method and the certainty of the evidence according to the GRADE method. The analysis was carried out with R software Version 4.2-3 using the Package for Meta-Analysis “meta” version 6.5-0.</p></div><div><h3>Results</h3><p>Eight randomized trials were included (with a total of 2342 patients), including four that focused specifically on mid-low rectal cancer (<em>n</em> <!-->=<!--> <!-->1,734 patients). No statistically significant difference was found for overall morbidity, intra-operative morbidity, anastomotic leakage, post-operative mortality, quality of mesorectal specimen, and resection margins. The main differences identified were a lower conversion rate for RS (RR<!--> <!-->=<!--> <!-->0.48 [0.24–0.95], <em>p<!--> </em>=<!--> <!-->0.04, I<sup>2</sup> <!-->=<!--> <!-->0%), and a longer operative time for RS (mean difference<!--> <!-->=<!--> <!-->39.11<!--> <!-->min [9.39–68.83], <em>p</em> <!--><<!--> <!-->0.01, I<sup>2</sup> <!-->=<!--> <!-->96%). The other differences had no real clinical relevance, i.e., resumption of flatus passage (5<!--> <!-->hours earlier after RS), and lymph node dissection (one more lymph node for LS).</p></div><div><h3>Conclusion</h3><p>This meta-analysis does not confirm the initial hypothesis and does not show a statistically significant or clinically relevant benefit of RS compared to LS for mid-low rectal cancer.</p></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"161 2","pages":"Pages 76-89"},"PeriodicalIF":2.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139736513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.1016/j.jviscsurg.2024.02.001
Edouard Roussel , Jean-Jacques Tuech , Marc Pocard
{"title":"Access to the abdominal cavity during laparotomy in obese patients","authors":"Edouard Roussel , Jean-Jacques Tuech , Marc Pocard","doi":"10.1016/j.jviscsurg.2024.02.001","DOIUrl":"10.1016/j.jviscsurg.2024.02.001","url":null,"abstract":"","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"161 2","pages":"Pages 141-143"},"PeriodicalIF":2.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139998047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.1016/j.jviscsurg.2023.10.005
Karem Slim , Frédéric Martin
In the healthcare sector, surgery (especially in the operating theatre) is responsible for emission of greenhouse gases, which is a source of global warming. The goal of this largely quantitative assessment is to address three questions on carbon footprint associated with surgery, the role of primary and secondary prevention prior to surgical procedures, and incorporation of the carbon footprint into judgment criteria in research and surgical innovations. It appears that while the impact of surgery on global warming is undeniable, its extent depends on means of treatment and geographical location. Before and after an operation, primary, secondary and tertiary prevention accompanied by surgical sobriety (avoiding unnecessary or unjustified actions) can be virtuous in terms of sustainable development. However, the sanitary benefits of these actions are often opposed to environmental benefit, which has yet to be satisfactorily assessed. Lastly, the carbon footprint has yet to be incorporated into research protocols or the innovations under development. This should impel us not only to sensitize the different healthcare actors to relevant issues, but also to improve working conditions.
{"title":"Surgery, innovation, research and sustainable development","authors":"Karem Slim , Frédéric Martin","doi":"10.1016/j.jviscsurg.2023.10.005","DOIUrl":"10.1016/j.jviscsurg.2023.10.005","url":null,"abstract":"<div><p><span>In the healthcare sector, surgery (especially in the operating theatre) is responsible for emission of greenhouse gases, which is a source of global warming. The goal of this largely quantitative assessment is to address three questions on carbon footprint associated with surgery, the role of primary and secondary prevention prior to surgical procedures, and incorporation of the carbon footprint into judgment criteria in research and surgical innovations. It appears that while the impact of surgery on global warming is undeniable, its extent depends on means of treatment and geographical location. Before and after an operation, primary, secondary and </span>tertiary prevention accompanied by surgical sobriety (avoiding unnecessary or unjustified actions) can be virtuous in terms of sustainable development. However, the sanitary benefits of these actions are often opposed to environmental benefit, which has yet to be satisfactorily assessed. Lastly, the carbon footprint has yet to be incorporated into research protocols or the innovations under development. This should impel us not only to sensitize the different healthcare actors to relevant issues, but also to improve working conditions.</p></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"161 2","pages":"Pages 63-68"},"PeriodicalIF":2.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138554836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.1016/j.jviscsurg.2023.11.004
Ninon Rouvière , Maria Pitard , Etienne Boutry , Michel Prudhomme , Martin Bertrand , Géraldine Leguelinel-Blache , Virginie Chasseigne
Healthcare sectors, particularly operating theaters, are major consumers of resources. Given today's climate-related issues, its seems vital that the different healthcare professionals in operating areas become aware of their roles. This is pronouncedly the case for hospital pharmacists, who fulfill cross-sectional functions in the proper use and management of healthcare products and sterile medical devices. The objective of this review of the literature is to identify the actions a hospital pharmacist can take to impel evolution toward ecologically responsible care in the operating theater. Seven areas in which a pharmacist can assume a leading, supporting or composite role in rendering an operating theater ecologically responsible have been highlighted: purchasing, procurement and storage, harmonization of practices, modification of practices, professional attire, waste elimination and research/teaching. The active participation of all healthcare professionals, including the hospital pharmacist, is essential to the development of a sustainable approach to healthcare.
{"title":"How a hospital pharmacist can contribute to a more sustainable operating theater","authors":"Ninon Rouvière , Maria Pitard , Etienne Boutry , Michel Prudhomme , Martin Bertrand , Géraldine Leguelinel-Blache , Virginie Chasseigne","doi":"10.1016/j.jviscsurg.2023.11.004","DOIUrl":"10.1016/j.jviscsurg.2023.11.004","url":null,"abstract":"<div><p>Healthcare sectors, particularly operating theaters, are major consumers of resources. Given today's climate-related issues, its seems vital that the different healthcare professionals in operating areas become aware of their roles. This is pronouncedly the case for hospital pharmacists, who fulfill cross-sectional functions in the proper use and management of healthcare products and sterile medical devices. The objective of this review of the literature is to identify the actions a hospital pharmacist can take to impel evolution toward ecologically responsible care in the operating theater. Seven areas in which a pharmacist can assume a leading, supporting or composite role in rendering an operating theater ecologically responsible have been highlighted: purchasing, procurement and storage, harmonization of practices, modification of practices, professional attire, waste elimination and research/teaching. The active participation of all healthcare professionals, including the hospital pharmacist, is essential to the development of a sustainable approach to healthcare.</p></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"161 2","pages":"Pages 37-45"},"PeriodicalIF":2.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138684089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.1016/j.jviscsurg.2023.12.007
Elena Belloni, Camélia Labiad, Gilles Manceau
{"title":"Ileosigmoid knotting, a rare but serious cause of intestinal obstruction","authors":"Elena Belloni, Camélia Labiad, Gilles Manceau","doi":"10.1016/j.jviscsurg.2023.12.007","DOIUrl":"10.1016/j.jviscsurg.2023.12.007","url":null,"abstract":"","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"161 2","pages":"Pages 156-157"},"PeriodicalIF":2.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140330263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}